Services and products for clinical and preclinical research
Stem cell and drug discovery scientists around the world use our solutions to translate their research into therapies.
For Cell Therapy Developers
End-to-End Solutions for Cell Therapy Development
REPROCELL enables cell therapy developers with integrated, regulatory-aligned solutions—from donor sourcing and cell derivation to gene editing and GMP manufacturing. We accelerate your path from discovery to the clinic. Our regulatory-aligned workflows deliver high-quality, reproducible, and clinically relevant human cells at every stage of development—enabling you to build scalable therapies without costly setbacks.
For Stem Cell Researchers
Advanced iPSC Tools and Services for Stem Cell Research
REPROCELL provides high-quality iPSC resources and tailored services to support your research from the start. From donor sourcing and footprint-free reprogramming to precise gene editing, our integrated capabilities simplify complex stem cell workflows.
Powered by StemRNA™ technology, we enable rapid generation of robust, reproducible iPSC lines, backed by comprehensive quality control for confidence in every experiment.
Focus on discovery, not process. Our streamlined, end-to-end approach reduces variability, saves time, and helps you generate reliable, publication- and decision-ready data.
For Diagnostic Developers
Supporting your preclinical research goals from bench to bedside
Whether you are identifying novel biomarkers, validating therapeutic targets, or translating discoveries toward clinical applications, REPROCELL provides the biospecimens, genomic analysis, and laboratory expertise to accelerate your research.
For Preclinical Drug Developers
De-risk your pipeline with human-relevant preclinical data
REPROCELL Biopta’s human tissue technology enables more accurate prediction of clinical success by using the most physiologically relevant models of human drug response.
By bridging the gap between animal studies and clinical trials, human tissue testing provides a powerful translational approach that improves clinical success rates and enhances the commercial value of preclinical assets through proof of concept in patient-derived living tissues.
▶ Drug Discovery Assay Catalog▶ Bioengineered 3D Tissue Models
For Clinical Drug Developers
Accelerate your clinical trials with reliable, high-integrity data
At REPROCELL, we coordinate, process, test, and analyze a wide range of fresh human biospecimens to support the full spectrum of clinical research. From study setup through to final data delivery, our integrated approach ensures seamless project execution, consistent sample quality, and reliable results across every stage.
With more than 25 years of experience in project and logistical management, we understand the complexities of global clinical trials and the importance of speed, precision, and compliance. Our GLP/GCLP and ISO-compliant systems operate 24/7, enabling rapid turnaround times while maintaining the highest standards of data integrity and regulatory adherence.
%20vial.jpg?width=517&height=1394&name=StemRNA%20human%20iPSCs%20(RCRP004N)%20vial.jpg)
